Jiangsu Hengrui Pharmaceuticals Co., Ltd.
600276 · Shanghai Stock Exchange (SSE) · Pharmaceuticals
Tentang perusahaan
Jiangsu Hengrui Pharmaceuticals is one of China's largest innovative pharmaceutical companies, with a major focus on oncology, anaesthesia, contrast agents, and metabolic disease therapeutics, and an extensive pipeline of novel small molecules and biologics in clinical development. The company has been investing heavily in drug innovation and has received approvals for several products in regulated international markets including the US and Europe. It is a privately controlled company headquartered in Lianyungang, Jiangsu Province.
| Bursa | Shanghai Stock Exchange (SSE) |
| Kode saham | 600276 |
| Sektor | Pharmaceuticals |
| Kapitalisasi pasar indikatif USD | $25.00B |
| Situs web | Kunjungi situs web |
Harga langsung
Memuat harga terkini…
| Kapitalisasi pasar | |
| Kisaran harian | |
| Kisaran 52 minggu |
Cara membeli
Di pasar asal (Shanghai Stock Exchange (SSE)), dapat diakses melalui broker global yang menawarkan bursa tersebut:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Shanghai Stock Exchange — pencatatan resmi di bursa
Hanya informasi ketersediaan — bukan rekomendasi atau penawaran untuk membeli. Konfirmasikan kelayakan, biaya, dan ketersediaan terkini dengan broker Anda.
Perusahaan lain di China
Data perusahaan dan harga langsung apa pun bersifat indikatif, mungkin tertunda atau tidak akurat, dan hanya untuk riset — bukan saran investasi. Verifikasi dengan bursa, pengajuan perusahaan, dan broker Anda.